BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 20663900)

  • 21. Combined administration of rituximab and on 013105 induces apoptosis in mantle cell lymphoma cells and reduces tumor burden in a mouse model of mantle cell lymphoma.
    Prasad A; Shrivastava A; Papadopoulos E; Kuzontkoski PM; Reddy MV; Gillum AM; Kumar R; Reddy EP; Groopman JE
    Clin Cancer Res; 2013 Jan; 19(1):85-95. PubMed ID: 23124440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclin D1 as a universally expressed mantle cell lymphoma-associated tumor antigen for immunotherapy.
    Wang M; Sun L; Qian J; Han X; Zhang L; Lin P; Cai Z; Yi Q
    Leukemia; 2009 Jul; 23(7):1320-8. PubMed ID: 19225534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclin D1 depletion induces DNA damage in mantle cell lymphoma lines.
    Mohanty S; Mohanty A; Sandoval N; Tran T; Bedell V; Wu J; Scuto A; Murata-Collins J; Weisenburger DD; Ngo VN
    Leuk Lymphoma; 2017 Mar; 58(3):676-688. PubMed ID: 27338091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Seliciclib (CYC202, R-Roscovitine) induces cell death in multiple myeloma cells by inhibition of RNA polymerase II-dependent transcription and down-regulation of Mcl-1.
    MacCallum DE; Melville J; Frame S; Watt K; Anderson S; Gianella-Borradori A; Lane DP; Green SR
    Cancer Res; 2005 Jun; 65(12):5399-407. PubMed ID: 15958589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bruton tyrosine kinase is commonly overexpressed in mantle cell lymphoma and its attenuation by Ibrutinib induces apoptosis.
    Cinar M; Hamedani F; Mo Z; Cinar B; Amin HM; Alkan S
    Leuk Res; 2013 Oct; 37(10):1271-7. PubMed ID: 23962569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. JNK is constitutively active in mantle cell lymphoma: cell cycle deregulation and polyploidy by JNK inhibitor SP600125.
    Wang M; Atayar C; Rosati S; Bosga-Bouwer A; Kluin P; Visser L
    J Pathol; 2009 May; 218(1):95-103. PubMed ID: 19206150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual targeting of the cyclin/Rb/E2F and mitochondrial pathways in mantle cell lymphoma with the translation inhibitor silvestrol.
    Alinari L; Prince CJ; Edwards RB; Towns WH; Mani R; Lehman A; Zhang X; Jarjoura D; Pan L; Kinghorn AD; Grever MR; Baiocchi RA; Lucas DM
    Clin Cancer Res; 2012 Sep; 18(17):4600-11. PubMed ID: 22791882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sorafenib inhibits cell migration and stroma-mediated bortezomib resistance by interfering B-cell receptor signaling and protein translation in mantle cell lymphoma.
    Xargay-Torrent S; López-Guerra M; Montraveta A; Saborit-Villarroya I; Rosich L; Navarro A; Pérez-Galán P; Roué G; Campo E; Colomer D
    Clin Cancer Res; 2013 Feb; 19(3):586-97. PubMed ID: 23231952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a clinically relevant chemoresistant mantle cell lymphoma cell culture model.
    He J; Hajj KA; Knapp CM; Whitehead KA
    Exp Biol Med (Maywood); 2019 Aug; 244(11):865-872. PubMed ID: 31208205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bortezomib and fenretinide induce synergistic cytotoxicity in mantle cell lymphoma through apoptosis, cell-cycle dysregulation, and IκBα kinase downregulation.
    Cowan AJ; Frayo SL; Press OW; Palanca-Wessels MC; Pagel JM; Green DJ; Gopal AK
    Anticancer Drugs; 2015 Oct; 26(9):974-83. PubMed ID: 26237500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FTY720 shows promising in vitro and in vivo preclinical activity by downmodulating Cyclin D1 and phospho-Akt in mantle cell lymphoma.
    Liu Q; Alinari L; Chen CS; Yan F; Dalton JT; Lapalombella R; Zhang X; Mani R; Lin T; Byrd JC; Baiocchi RA; Muthusamy N
    Clin Cancer Res; 2010 Jun; 16(12):3182-92. PubMed ID: 20460491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct BTK inhibitors differentially induce apoptosis but similarly suppress chemotaxis and lipid accumulation in mantle cell lymphoma.
    Liu Z; Liu J; Zhang T; Li L; Zhang S; Jia H; Xia Y; Shi M; Zhang J; Yue S; Chen X; Yu J
    BMC Cancer; 2021 Jun; 21(1):732. PubMed ID: 34174847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cyclin-dependent kinase inhibitor SNS-032 has single agent activity in AML cells and is highly synergistic with cytarabine.
    Walsby E; Lazenby M; Pepper C; Burnett AK
    Leukemia; 2011 Mar; 25(3):411-9. PubMed ID: 21212792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell cycle alterations in the blastoid variant of mantle cell lymphoma (MCL-BV) as detected by gene expression profiling of mantle cell lymphoma (MCL) and MCL-BV.
    de Vos S; Krug U; Hofmann WK; Pinkus GS; Swerdlow SH; Wachsman W; Grogan TM; Said JW; Koeffler HP
    Diagn Mol Pathol; 2003 Mar; 12(1):35-43. PubMed ID: 12605034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. JARID1B deletion induced apoptosis in Jeko-1 and HL-60 cell lines.
    Su H; Ma X; Huang Y; Han H; Zou Y; Huang W
    Int J Clin Exp Pathol; 2015; 8(1):171-83. PubMed ID: 25755704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of the proteasome induces cell cycle arrest and apoptosis in mantle cell lymphoma cells.
    Bogner C; Ringshausen I; Schneller F; Fend F; Quintanilla-Martinez L; Häcker G; Goetze K; Oostendorp R; Peschel C; Decker T
    Br J Haematol; 2003 Jul; 122(2):260-8. PubMed ID: 12846895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antitumoral activity of lenalidomide in in vitro and in vivo models of mantle cell lymphoma involves the destabilization of cyclin D1/p27KIP1 complexes.
    Moros A; Bustany S; Cahu J; Saborit-Villarroya I; Martínez A; Colomer D; Sola B; Roué G
    Clin Cancer Res; 2014 Jan; 20(2):393-403. PubMed ID: 24178620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism of the antitumoral activity of deferasirox, an iron chelation agent, on mantle cell lymphoma.
    Vazana-Barad L; Granot G; Mor-Tzuntz R; Levi I; Dreyling M; Nathan I; Shpilberg O
    Leuk Lymphoma; 2013 Apr; 54(4):851-9. PubMed ID: 23020673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biological rational for sequential targeting of Bruton tyrosine kinase and Bcl-2 to overcome CD40-induced ABT-199 resistance in mantle cell lymphoma.
    Chiron D; Dousset C; Brosseau C; Touzeau C; Maïga S; Moreau P; Pellat-Deceunynck C; Le Gouill S; Amiot M
    Oncotarget; 2015 Apr; 6(11):8750-9. PubMed ID: 25797245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Silencing of LSD1 gene modulates histone methylation and acetylation and induces the apoptosis of JeKo-1 and MOLT-4 cells.
    Zou ZK; Huang YQ; Zou Y; Zheng XK; Ma XD
    Int J Mol Med; 2017 Aug; 40(2):319-328. PubMed ID: 28627608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.